Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 17, 2020

SELL
$42.0 - $48.25 $5.06 Million - $5.81 Million
-120,468 Closed
0 $0
Q3 2019

Oct 03, 2024

BUY
$40.46 - $43.52 $4.91 Million - $5.28 Million
121,378 New
121,378 $5.18 Million
Q2 2019

Oct 03, 2024

BUY
$39.4 - $42.7 $4.78 Million - $5.18 Million
121,378 New
121,378 $4.86 Million
Q2 2019

Jul 23, 2019

SELL
$39.4 - $42.7 $58,351 - $63,238
-1,481 Reduced 1.21%
120,468 $4.82 Million
Q1 2019

Oct 03, 2024

BUY
$38.57 - $42.69 $4.74 Million - $5.24 Million
122,859 New
122,859 $5.13 Million
Q1 2019

May 13, 2019

SELL
$38.57 - $42.69 $296,603 - $328,286
-7,690 Reduced 5.93%
121,949 $5.1 Million
Q4 2018

Oct 03, 2024

BUY
$37.8 - $42.69 $4.93 Million - $5.57 Million
130,549 New
130,549 $4.99 Million
Q4 2018

Feb 06, 2019

SELL
$37.8 - $42.69 $489,887 - $553,262
-12,960 Reduced 9.09%
129,639 $4.95 Million
Q3 2018

Oct 04, 2024

BUY
$39.75 - $42.69 $5.7 Million - $6.13 Million
143,509 New
143,509 $5.77 Million
Q3 2018

Nov 13, 2018

BUY
$39.75 - $42.69 $413,797 - $444,402
10,410 Added 7.88%
142,599 $5.73 Million
Q2 2018

Oct 04, 2024

BUY
$39.61 - $42.76 $5.27 Million - $5.69 Million
133,099 New
133,099 $5.37 Million
Q2 2018

Aug 10, 2018

SELL
$39.61 - $42.76 $486,806 - $525,520
-12,290 Reduced 8.51%
132,189 $5.33 Million
Q1 2018

Oct 04, 2024

SELL
$36.18 - $40.15 $830,584 - $921,723
-22,957 Reduced 13.64%
145,389 $5.68 Million
Q1 2018

May 01, 2018

SELL
$36.18 - $40.15 $863,508 - $958,260
-23,867 Reduced 14.18%
144,479 $5.65 Million
Q4 2017

Oct 04, 2024

BUY
$35.34 - $41.9 $5.95 Million - $7.05 Million
168,346 New
168,346 $5.97 Million
Q4 2017

Jan 26, 2018

BUY
$35.34 - $41.9 $5.19 Million - $6.16 Million
146,960 Added 687.18%
168,346 $5.97 Million
Q3 2017

Nov 13, 2017

BUY
$39.44 - $41.55 $321,199 - $338,383
8,144 Added 61.5%
21,386 $868,000
Q2 2017

Aug 09, 2017

BUY
N/A
13,242
13,242 $571,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Commerzbank Aktiengesellschaft Portfolio

Follow Commerzbank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.